Ngernsombat C, Suriya U, Udompaisarn S, Panomchoeng N, Janvilisri T. Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses. EXCLI J. [Internet]. 2026 Jan. 16 [cited 2026 Sep. 15];25:204-21. Available from: https://www.excli.de/excli/article/view/9094